<DOC>
	<DOCNO>NCT00893334</DOCNO>
	<brief_summary>The purpose study understand biochemistry different type Limb-Girdle Muscular Dystrophy ( LGMD ) determine appropriate outcome measure future clinical treatment trial LGMD . It conduct two site Cooperative International Neuromuscular Research Group ( CINRG ) . It involve one day clinical evaluation participate institution take approximately four six hour , involve strength test muscle functional test physical therapist , evaluation physician , pulmonary function testing , complete cardiac evaluation electrocardiogram ( ECG EKG ) echocardiogram ( Echo ) , involve two blood draw , one evaluation one evaluation complete . During visit , participant ask fill couple questionnaire ask question quality life activity limitation , well his/her understand diagnosis regard etiology ( cause muscle disorder ) , genetics , inheritance muscle disorder .</brief_summary>
	<brief_title>Evaluation Limb-Girdle Muscular Dystrophy</brief_title>
	<detailed_description>Specific Aims : Aim 1 : Evaluate integrity extracellular matrix patient LGMD measure serum growth factor cytokine compare disease control ( BMD ) normal volunteer . Aim 2 : Measure growth factor cytokines follow medical evaluation compare baseline level . Aim 3 : Discovery Aim future multicenter clinical trial LGMD . Aim 3A : Abstract medical record particular emphasis age disease onset , initial clinical symptom , progression location muscular weakness , treatment attempt , medical complication . A review diagnostic testing perform also conduct . Aim 3B : Perform complete clinical evaluation include anthropometric measure , evaluation joint limitation , time functional testing , muscle strength , pulmonary function , cardiac assessment . Aim 3C : Determine patient understand diagnosis LGMD genetic testing result . A questionnaire generate address patient 's understanding his/her diagnosis well understanding genetic concept autosomal recessive inheritance , gene , molecular test implication well family . Aim 3D : Quality Life ( QOL ) questionnaires administer . These use identify functional limitation patient compare limitation clinical evaluation . Study Description Only one visit necessary study . The study visit include : 1. Review inform consent form 2 . Blood collection Blood collect follow : DNA extraction confirm genotype already perform ; Muscle Enzymes physical evaluation ; Growth factor cytokine : physical evaluation . 3 . Medical history review 4 . Physical Examination 5 . Questionnaires : Participants complete 3 questionnaire : Diagnosis genetic testing , ACTIVLIM , INQoL 6 . Clinical Evaluator assessment include : Manual Muscle Testing , Quantitative Muscle Testing , Pulmonary Function Testing , Anthropometric measurement , Timed Functional test 7 . Cardiac evaluation include : Electrocardiogram Echocardiogram Control subject require come test site complete informed consent process , clinical evaluator assessment , blood drawn clinical evaluator assessment . No examination procedure perform control participant .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Muscular Dystrophies , Limb-Girdle</mesh_term>
	<criteria>18 year age old . Diagnosis LGMD2I , LGMD2A , LGMD2B , BMD determine muscle biopsy immunohistochemistry , immunoblotting , molecular analysis . Able travel study site Normal control recruit either friend study participant separate recruitment . Unable travel study site . Do diagnosis LGMD2I , LGMD2A , LGMD2B , BMD review clinical testing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Duchenne Becker muscular dystrophy</keyword>
	<keyword>muscular dystrophy</keyword>
</DOC>